International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8248105
Original Article
Study of Who Maternal Near Miss Using Organ Dysfunction to Predict Maternal Outcome
 ,
 ,
Published
Aug. 10, 2023
Abstract

Background and Aims: The objective of this study was to determine maternal near miss frequency and maternal near miss to mortality ratio by using organ dysfunction criteria to analyze the trends of maternal near miss and to compare the nature of near miss events with that of maternal mortality.

Methodology: The study was conducted during July 2021 – December 2021 on all the maternal near miss cases who were admitted in Sultania Zanana Hospital. The cases of “near miss” were compared to maternal death using organ dysfunction.

Results: During our study period, total number of obstetric admissions were 8667 out of which maternal near miss cases were 500 and so incidence of maternal near miss was 5.76%. Cardiovascular (30.38%) and Respiratory organ dysfunction (33.87%) were maximum which were responsible for maternal near miss. The maternal near miss: mortality ratio was 7.8.

Conclusion: In this study, we used WHO criteria which cover almost all possible organ systems which can be affected secondary to any pregnancy-related complications. The WHO criteria for maternal near miss showed to be able to identify all cases of death and almost all cases of organ failure. Therefore, they allow evaluation of the severity of the complication and consequently enable clinicians to build a plan of care or to provide an early transfer for appropriate reference centers.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
489 Views
176 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved